This inventor holds 1 USPTO granted patent. Top assignee: Societe Cooperative Agricole Laitiere D'artois Et Des Flandres, La. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: The Innovative Contributions of Alain Driou
Introduction
Alain Driou is a notable inventor based in Laxou, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for convulsions and anxiety. His work exemplifies the intersection of science and innovation, showcasing how new ideas can lead to advancements in medicine.
Latest Patents
Driou holds a patent for the use of a decapeptide with benzodiazepine-type activity. This invention relates to the preparation of medicines that utilize a decapeptide with the amino acid sequence of SEQ ID NO.:1. The patent highlights the potential of this decapeptide in creating effective treatments for conditions such as convulsions and anxiety. Additionally, it encompasses pharmaceutical compositions, food supplements, and foodstuffs for special diets that incorporate this innovative decapeptide.
Career Highlights
Alain Driou is associated with the Société Coopérative Agricole Laitière D'Artois et des Flandres, where he has been able to apply his expertise in the development of new medicinal products. His career reflects a commitment to advancing healthcare through innovative solutions.
Collaborations
Driou has collaborated with notable colleagues, including Laurent Miclo and Emmanuel Perrin. These partnerships have likely contributed to the success of his projects and the development of his patented inventions.
Conclusion
Alain Driou's work in the field of pharmaceuticals demonstrates the importance of innovation in addressing health challenges. His contributions, particularly through his patent, highlight the potential of new compounds in the treatment of anxiety and convulsions. Driou's career serves as an inspiration for future inventors in the medical field.